RA

Rosmina Ahmed

Director Director DIN 10588274
DIN 10588274 First appointment Apr 2024 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2024
Shareholding value Locked Premium profile

About Rosmina Ahmed

Data last updated:

Rosmina Ahmed has 2 years in corporate governance. Formerly with 1 company, such as Aritac Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10588274
Primary Designation Director
First Appointment 11 Apr 2024
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Aritac Pharma Private Limited U47721AS2024PTC026282
Director11 Apr 20242024Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aritac Pharma Private Limited
Premium access

Shareholding and investment profile for Rosmina Ahmed

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rosmina Ahmed

Rosmina Ahmed has 2 years in corporate governance. Formerly with 1 company, such as Aritac Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Rosmina Ahmed is associated with 0 companies as a director.

Rosmina Ahmed has expertise in General Business.

Rosmina Ahmed has 2 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available